APA (7th ed.) Citation

TUTTLE, K. R., WILSON, J. M., LIN, Y., QIAN, H., KELLY-BORUFF, K., GENOVESE, F., . . . BOTROS, F. T. (2020). 949-P: Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease. Diabetes, 69, N.PAG. https://doi.org/10.2337/db20-949-P

Chicago Style (17th ed.) Citation

TUTTLE, KATHERINE R., JONATHAN M. WILSON, YANZHU LIN, HUI-RONG QIAN, KATHLEEN KELLY-BORUFF, FEDERICA GENOVESE, MORTEN A. KARSDAL, KEVIN L. DUFFIN, and FADY T. BOTROS. "949-P: Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease." Diabetes 69 (2020): N.PAG. https://doi.org/10.2337/db20-949-P.

MLA (9th ed.) Citation

TUTTLE, KATHERINE R., et al. "949-P: Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease." Diabetes, vol. 69, 2020, p. N.PAG, https://doi.org/10.2337/db20-949-P.